{"Title": "Vascular disease and type 2 diabetes: The science policy case for early cardiometabolic intervention", "Year": 2019, "Source": "Cardiovasc. Endocrinol. Metab.", "Volume": "8", "Issue": 2, "Art.No": null, "PageStart": 49, "PageEnd": 50, "CitedBy": 3, "DOI": "10.1097/XCE.0000000000000171", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075141948&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85075141948", "SubjectAreas": [["Endocrinology, Diabetes and Metabolism", "MEDI", "2712"], ["Cardiology and Cardiovascular Medicine", "MEDI", "2705"]], "AuthorData": {"57194516384": {"Name": "Taylor D.", "AuthorID": "57194516384", "AffiliationID": "60016379, 60023957", "AffiliationName": "UCL School of Pharmacy Offices, BMA/Tavistock House"}}}